Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

13.2K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.2K
Subviral Agents01:29

Subviral Agents

889
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
889
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

11
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
11
The Proteasome01:13

The Proteasome

2.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential associations of lipid profile and genetic susceptibility with sleep duration.

Lipids in health and disease·2026
Same author

Age-dependent peripheral dissemination of α-synuclein seeds: mechanistic basis for blood-based early detection of Parkinson's disease.

Acta neuropathologica communications·2026
Same author

Incomplete protection of the K<sub>222</sub> polymorphism of the prion protein gene after intracerebral exposure to caprine BSE in goats: preliminary follow-up in S<sub>127</sub> carriers.

Veterinary research·2026
Same author

Joint associations of grip strength, lipid levels, and lipid-related genetic risk with atrial fibrillation.

Lipids in health and disease·2026
Same author

Astrocyte-related proteins mediate the association of YWHAG with Alzheimer's pathology and enhance its diagnostic value.

Translational psychiatry·2026
Same author

Overexpression of bank vole PrP(I109) in mice induces a spontaneous atypical prion disease with sex-dependent onset, early NfL elevation, and universal prion strain permissiveness.

Acta neuropathologica communications·2026

Related Experiment Video

Updated: Apr 20, 2026

Protein Misfolding Cyclic Amplification of Prions
10:12

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

20.3K

Prions in variably protease-sensitive prionopathy: an update.

Wen-Quan Zou1, Pierluigi Gambetti2, Xiangzhu Xiao3

  • 1Department of Pathology Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA. wenquan.zou@case.edu.

Pathogens (Basel, Switzerland)
|December 2, 2014
PubMed
Summary

Variably protease-sensitive prionopathy (VPSPr) presents unique prion characteristics and pathogenesis. Research into these atypical prions enhances understanding of human prion diseases, including Creutzfeldt-Jakob disease (CJD).

More Related Videos

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012

11.3K
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

16.8K

Related Experiment Videos

Last Updated: Apr 20, 2026

Protein Misfolding Cyclic Amplification of Prions
10:12

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

20.3K
Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012

11.3K
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

16.8K

Area of Science:

  • Neuroscience
  • Prion Biology
  • Molecular Pathology

Background:

  • Human prion diseases involve abnormal prion protein (PrPSc) formation from normal cellular isoforms (PrPC).
  • Variably protease-sensitive prionopathy (VPSPr) is an atypical human prion disease with distinct clinical and neuropathological features.
  • The specific nature of PrPSc in VPSPr and its pathogenesis remain largely unclear.

Purpose of the Study:

  • To review the physicochemical and biological properties of prions in VPSPr.
  • To discuss the pathogenesis of VPSPr, focusing on the origin and formation of its unique prions.
  • To explore the potential implications of VPSPr findings for understanding other prion diseases.

Main Methods:

  • Review of existing literature on VPSPr.
  • Analysis of physicochemical properties of VPSPr prions.
  • Discussion of biological characteristics and pathogenic mechanisms.

Main Results:

  • VPSPr is characterized by a peculiar PrPSc deposition in the brain.
  • Recent findings suggest a possible association between VPSPr and a genetic prion disease with a specific PrP mutation (V180I).
  • The unique features of VPSPr prions offer insights into prion formation and disease mechanisms.

Conclusions:

  • Understanding the unique properties of VPSPr prions is crucial for elucidating its pathogenesis.
  • Investigating VPSPr may provide broader insights into the molecular mechanisms underlying all human prion diseases.
  • Further research into VPSPr is essential for advancing diagnostics and therapeutics for prionopathies.